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Available online 24 June 2014Recessively inherited loss-of-functionmutations in the PTEN-induced putative kinase 1(Pink1), DJ-1 (Park7) and
Parkin (Park2) genes are linked to familial cases of early-onset Parkinson's disease (PD). As part of its strategy to
provide more tools for the research community, The Michael J. Fox Foundation for Parkinson's Research (MJFF)
funded the generation of novel ratmodelswith targeted disruption ofPink1, DJ-1 or Parkin genes and determined
if the loss of these proteins would result in a progressive PD-like phenotype. Pathological, neurochemical and
behavioral outcome measures were collected at 4, 6 and 8 months of age in homozygous KO rats and compared
to wild-type (WT) rats. Both Pink1 and DJ-1 KO rats showed progressive nigral neurodegeneration with about
50% dopaminergic cell loss observed at 8 months of age. ThePink1 KO and DJ-1 KO rats also showed a two to
three fold increase in striatal dopamine and serotonin content at 8 months of age. Both Pink1 KO and DJ-1 KO
rats exhibited signiﬁcant motor deﬁcits starting at 4 months of age. However, Parkin KO rats displayed normal
behaviors with no neurochemical or pathological changes. These results demonstrate that inactivation of the
Pink1 or DJ-1 genes in the rat produces progressive neurodegeneration and early behavioral deﬁcits, suggesting
that these recessive genesmay be essential for the survival of dopaminergic neurons in the substantia nigra (SN).
These MJFF-generated novel rat models will assist the research community to elucidate the mechanisms by
which these recessive genes produce PD pathology and potentially aid in therapeutic development.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).Introduction
Parkinson's disease (PD) is the second most common neurode-
generative disorder and is characterized clinically by tremor, rigidi-
ty, bradykinesia and postural instability. Pathologically, the disease
is associated with loss of dopaminergic neurons in the substantia
nigra (SN), decreased dopamine (DA) neurotransmission and theect.com).
. This is an open access article underpresence of neuronal intracellular Lewy body (LB) inclusions
(Lees et al., 2009).While PD is a complex, multifactorial disease
and largely sporadic, rare familial forms of the disease have been corre-
lated to speciﬁc genetic mutations that are inherited in Mendelian
fashion (Farrer, 2006).Mutations in alpha-synuclein (aSyn) and leucine
rich-repeat kinase 2 (LRRK2) have been linked to autosomal-dominant
forms of PD (Martin et al., 2011). Mutations in the Pink1, DJ-1 and
Parkin genes have been causally linked to autosomal recessive PD
with early age of onset, slow progression of the disease, and a more
selective loss of DA neurons than that associated with sporadic late-
onset PD (Houlden and Singleton, 2012). Discovery of rare familial
monogenic forms of PD has provided new targets to pursue for drugthe CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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understand the functions of these genes.
Knockout (KO)mice lacking Pink1, DJ-1 or Parkin genes show subtle
behavioral and neurochemical abnormalities. For example, Pink1 KO
mice exhibit decreased DA release in striatal slices and impairments in
plasticity (Kitada et al., 2007)while the Parkin KOmice exhibit increased
striatal extracellularDA concentration andbehavioral deﬁcits (Goldberg
et al., 2003). Similarly, DJ-1 KO mice show reduced DA overﬂow in the
striatum, dysfunction in long-term potentiation and hypoactivity
(Goldberg et al., 2005). Neither nigral cell loss nor alpha-synuclein
aggregation was observed in these single gene KO mice. Triple KO
mice lacking Pink1, DJ-1 and Parkin genes do not exhibit abnormal
behavior or reduced DA neuron number up to 24 months of age,
although evoked dopamine release and striatal synaptic plasticity are
impaired (Kitada et al., 2009). More recently, DJ-1 KO mice fully
backcrossed to a C57BL/6 J backgrounds howed early-onset unilateral
loss of nigral DA neurons, which progressed to bilateral degeneration
with age (Rousseaux et al., 2012).This variability in phenotypes and
lack of predictive validity to human PD has limited our understanding
of the biologic function of these genes and hindered our ability to
develop therapies against these targets.
The Michael J. Fox Foundation for Parkinson's Research (MJFF)
directly sponsors generation, characterization, and distribution of
animal models to increase availability and accessibility of these much
needed tools to accelerate Parkinson's research (Baptista et al., 2013).
As part of this overall strategy, MJFF funded generation of novel rat
knockout models of Pink1, DJ-1, and Parkin genes using Zinc Finger
Nuclease (ZFN) Technology. This technology enables rapid creation
of targeted gene knockouts, genomic insertions or gene editing in
eukaryotes (Geurts et al., 2009). The current study describes detailed
behavioral, neurochemical and pathological characterization of these
models for possible PD-like features. Results how that Pink1 KO and
DJ-1 KO, but not Parkin KO rats, have early motor deﬁcits and exhibit
a progressive loss of SN DA neurons.
Methods
Generation of Pink1, DJ-1 and Parkin knockout rats
Animal husbandry
Creation and preliminary characterization of KO rats was performed
at SAGE Labs, which operated under approved animal protocols
overseen by SAGE's Institutional Animal Care and Use Committee
(IACUC). Long EvansHooded rats (Crl:LE) fromCharles River Laboratories
International Inc. (Wilmington, MA) were used for both microinjection
and breeding. Long Evans rats were chosen due to better visual function
observed in the pigmented strains (as opposed to albino strains)
(Prusky et al., 2002), which may aid in testing for behavioral tasks that
involve vision. Rats were housed in standard cages on IVC racks and
maintained on a 12 h light/dark cycle with ad libitum access to food and
water. Routine health monitoring of the colony was performed at IDEXX
(Columbia, MO) and revealed no evidence of infection with serious
known pathogens. Rats were housed two per cage and body weights
were collected weekly. Separate groups of knockout rats or Long Evans
WT rats were aged up to 4, 6, or 8 months and were sent for phenotypic
characterization at one of two contract research organizations: WIL
Research Labs (Ashland, OH) or Psychogenics, Inc (Tarrytown, NY).
ZFN mRNA preparation and microinjections
A pair of active ZFNs each speciﬁc for Pink1, DJ-1 or Parkin was
obtained from the CompoZr product line (Sigma, St. Louis, MO).
mRNA was prepared from each construct linearized with XhoI restric-
tion enzyme and using MessageMax and Poly(A) polymerase tailing
kits (Epicentre Biotechnology, Madison, WI), puriﬁed, quantiﬁed, com-
bined (1:1 ratio), and transfected into rat C6 cells for activity validation.
Four to ﬁve week-old donors were injected with 20 units of Pregnantmare serum gonadotropin (PMS) followed by 50 units of human
chorionic gonadotropin (hCG) injection 48 h after the PMS injection
and then immediately mated with stud males after the hCG injection.
Fertilized eggs were harvested a day later for mating. ZFN mRNA
was microinjected at 10 ng/μl into the pronucleus of fertilized eggs.
Following microinjection, 25–30 eggs were transferred into each
pseudopregnant female, which gave birth to the founder generation.
Founder identiﬁcation and breeding
Tail or toe biopsies were used for genomic DNA extraction and
analysis as described previously (Carbery et al., 2010). Primers ﬂanking
the target sites used for genotyping are Pink1FWD 5′-CCATGGGCAGGA
ACACTATT; Pink1REV 5′-CCTACACACAGCCCTCACCT; DJ-1 FWD,
5′-TATTGGGCCTTTCTCTTGGA; DJ-1 REV, AGACAGGAGTTCATGCCA
CC; Parkin FWD 5′-GGTGTCTTGGCTCAGTGTGA; and Parkin Rev
5′-GCCACCCAGAATAGCATCTC.The chosen founder was then bred
to a wild type rat to obtain heterozygous rats, and sibling mating of
heterozygotes resulted in homozygous knockout rats. To differentiate
wild type, heterozygotes and homozygotes, 100 bp regions are ampli-
ﬁed to distinguish the 26 bp and 8 bp deletion in size in Pink1 and
DJ-1, respectively, by using Pink1 50 bp F, 5′-CCCTGGCTGACTATCC
TGAC; Pink1 50 bp R, 5′-CCACCACCCACTACCACTTACT; DJ-1 50 bp F,
5′-TGGGAGTGACAGTCTCAGTGG; and DJ-1 50 bp R, 5′-AGCTATGA
GGCCCTTCCTGT. Homozygous and heterozygous Parkin KO rats
were conﬁrmed to contain the 5-bp deletion by sequencing the PCR
amplicon with above primers.
RNA preparation and qRT-PCR
Knockout andwild type littermateswere sacriﬁced for tissue harvest
at 5–9weeks of age. Brain tissueswere dissected and stored in RNAlater
solution (Ambion, Austin, TX) at 4 °C. Total RNA was extracted using
Trizol reagent (Sigma, Saint Louis, MO). First strand cDNA was syn-
thesized from 1 μg of total RNA that had been treated using DNase
(Ambion) by using the oligo(dT)20 primer and SuperscriptIII reverse
transcriptase (Life Technology, Carlsbad, CA). Reverse transcription
was carried out with 1 cycle of 50 °C for 50 min and 85 °C for
5 min. qPCR analyses were carried out with 1 μL of total RNA using
SYBR Green (Sigma) with forward primer (5′-CATGGCTTTGGATG
GAGAGT) and reverse primer (5′-TGGGAGTTTGCTCTTCAAGG) for
Pink1; forward primer (5′-CGATGTGGTTGTTCTTCCAG) and reverse
primer (5′-GCCGTTCATCATTTTGTCCT) for DJ-1;and forward primer
(5′-CTGGCAGTCATTCTGGACAC) and reverse primer (5′-CTCTCCAC
TCATCCGGTTTG) for Parkin. β-Actin was used as the reference
gene ampliﬁed with forward primer (5′-GGCATCCTGACCCTGAAGTA)
and reverse primer (5′-GGGGTGTTGAAGGTCTCAAA). qPCR were
carried out using 1 cycle of 94 °C for 2 min followed by 40 cycles of
94 °C for 15 sec and 60 °C for 30 sec for ampliﬁcation. The data were
presented as relative gene expression andwere calculated using BioRad
software (ΔΔCt).
Western blot
Male KO andWT littermateswere sacriﬁced for tissue harvest at 5–9
weeks of age. Brain and heart tissues were dissected and immediately
frozen in liquid nitrogen and stored at −80 °C. Tissues were dounce
homogenized in 400 μL RIPA buffer (Sigma) ± 4× Protease inhibitor
cocktail (Sigma) and incubated on ice for 1 hour with 15 second
vortexing every 15 minutes. Then, the homogenate was centrifuged at
14000 X g for 5 min at 4 °C. Supernatant was then mixed with an
equal volume of 2× Laemmli buffer (Sigma). Samples were denatured
at 100 °C for 5 minutes before loading. After denaturation, 15 μL of
lysatewas loaded on a TGX4–20% precast gel (Bio-Rad) and electropho-
resed at 200 V for 25 minutes. The resolved gel was transferred to
0.45 μm nitrocellulose membrane (Bio-Rad) by wet transfer apparatus
(Bio-Rad) for 60 min at 100 V. The transfer buffer contained standard
tris-glycine salts, 20% MeOH, and 0.25% SDS. Transfer efﬁciency was
analyzed using a Ponceau S (Sigma) stain. The membrane was then
192 K.D. Dave et al. / Neurobiology of Disease 70 (2014) 190–203washed 2× for 5 min with water and blocked for 60 min in Western
Block solution (Sigma). After blocking, the membrane was washed
3× for 5 min in 1× TBS-T and incubated for 60min in primary antibody
solution (DJ-1 antibody, Sigma, #SAB4500248, at 1:1000 dilution in
Western Block solution). After the incubation, the membrane was
washed 5× 5 min in 1× TBS-T and incubated with the secondary
antibody (Jackson Immunolab, goat-anti rabbit, at 1:50,000 dilution)
for 30min. Themembranewaswashed 5× in 1× TBST-T and incubated
for 2 min in Supersignal West Pico substrate (Thermo Scientiﬁc,
Waltham, MA) and visualized on a ChemiDoc XRS ± (Bio-Rad).
β-Actin was used as internal control for normalizing total input
proteins. Parkinwestern analysis was performed on brain homogenates
from wild-type and Parkin KO rats essentially as described above,
using rabbit anti-Parkin (#2132, Chemicon) and mouse anti-Parkin
(MAB5512, Millipore).
Detailed characterization of KO rats – behavior, neurochemistry and
pathology
Behavioral phenotyping at WIL research labs
Upon arrival from SAGE Labs, all animals were gang-housed in the
same way (2 per cage), in clean, wire-mesh cages suspended above
cage-board. Rats were housed throughout the acclimation period
(at least 5 days) and during the behavioral testing phase in an
environmentally controlled room. Controls were set to maintain a
temperature of 20–23 °C, a relative humidity of approximately
30–70%, and a 12-h light/12-h dark photoperiod. The basal diet
used in these studies, PMI Nutrition International, LLC, Certiﬁed
Rodent LabDiet 5002, is a certiﬁed feed with appropriate analyses
performed by the manufacturer and provided to WIL Research.
Reverse osmosis-treated (on-site) drinking water, delivered by an
automatic watering system, was provided ad libitum throughout
the study period. The protocols were reviewed and approved by
the WIL Research Institutional Animal Care and Use Committee
(IACUC).Animals were maintained in accordance with the “Guide
for the Care and Use of Laboratory Animals” (National Research
Council, 1996).On the ﬁrst behavioral testing day, male homozygous
knockouts of Pink1, DJ-1, Parkin or LE WT (n = 15/group/age) were
ﬁrst tested for behavioral deﬁcits in the functional observational
battery (FOB) test followed at least an hour later in the accelerating
rotarod test paradigm. Rats were subjected to rotarod for 4 addition-
al days (for a total of 5 days). The 15 rats/group were then random-
ized into 2 subsets. Subset A consisted of 9 rats which were assigned
for neuropathology. Subset B consisted of 6 rats which were assigned
to neurochemistry.
Behavioral phenotyping at Psychogenics, Inc.
During the course of the study, 12 /12 light/dark cycles and a room
temperature of 20 to 23 °C were maintained with relative humidity
maintained around 50%. Food and water were provided ad libitum for
the duration of the study. Wet feed was also provided to animals
when their body weight declined or when they displayed hindlimb
deﬁcits. Animals were monitored for survival and health statuses
twice per day and body weighed once per week for the duration
of the study. For these experiments, male homozygous knockouts
of Pink1, DJ-1 and LE WT rats (n = 7/group) were tested at 4 months
of age for their motor performance in the Tapered balance beam test,
grip-strength, open-ﬁeld apparatus, and NeuroCube. The same animals
were then re-tested at 6 and 8 months of age.
Behavioral outcome measures
Functional observational battery (FOB). Testing was performed by
the same technicians, whenever possible, without knowledge of the
animals' group assignment. The FOB was performed in a sound-
attenuated room equipped with a white noise generator set to
operate at 70 ± 10 dB. All animals were observed for the followingparameters: home cage observations [posture, convulsions/tremors,
feces consistency, biting, palpebral (eyelid) closure]; handling obser-
vations (ease of removal from cage, lacrimation/chromodacryorrhea,
piloerection, palpebral closure, eye prominence, red/crusty deposits,
ease of handling animal in hand, salivation, fur appearance, respiratory
rate/character, mucous membranes/eye/skin color, muscle tone),
open ﬁeld observations (evaluated over a 2-min observation period)
(mobility, rearing, convulsions/tremors, grooming, bizarre/stereotypic
behavior, time to ﬁrst step, gait, arousal, urination/defecation, gait
score, backing),sensory observations (approach response, startle re-
sponse, pupil response, forelimb extension, air righting reﬂex, touch re-
sponse, tail pinch response, eyeblink response, hindlimb extension,
olfactory orientation), neuromuscular observations (hindlimb extensor
strength, hindlimb foot splay, grip strength-hind and forelimb, rotarod
performance), and physiological observations (catalepsy, body
temperature, body weight).
NeuroCube® (NC). The NeuroCube® system is a platform that
employs computer vision to detect changes in gait geometry and gait
dynamics in rodents. The NC apparatus used in the current study was
a circular arena (76.2 cm wide and 7.6 cm high), where the rats were
allowed to walk in a circle. Rats were ﬁrst allowed to acclimate in the
experimental room for 1 h prior to test. Following acclimation to the
test room, rats were placed in the NC system and allowed to walk in
the apparatus for a 5-min session. Digital videos of the rats were
processed using proprietary computer vision algorithms to extract
behavioral characteristics (features) that were further fed into a
machine learning algorithm that quantiﬁed phenotype differences
(as described in Appendix A). Splay, stride/swing duration, base
length/width, paw position coordinates, paw pressure distribution
and body contour movement are examples of the 124 total features
that NeuroCube platform is capable to capture. These features
together constitute a quantiﬁable “phenotypic signature” for each
group of rats which can be also visualized for quick qualitative
assessment (e.g. a heat map of paw placement – see Fig. 5).
Tapered balance beam (TBB). TBB consists of a strip of smooth black
acrylic 165 cm in length, with a square cross section that tapers from a
width of 6 cm to 1.5 cm. The surface of the beam was covered with a
thin layer of rubber to provide traction. A safety ledge (0.5 cm) was
located 2 cm below the beam. The ledge maintained a constant width
of 0.5 cm as the beam tapers. The angle of the beam was 17° from
horizontal, running from low to high. The highest point of the beam
was ~58 cm from the ﬂoor. At the “end” portion of the balance beam,
there was a goal box, which rests on the aforementioned support
stand. The goal box was constructed from black acrylic, measuring
25 cm3 and containing a 10 cm2 entrance hole. Padding under the
beam was used in the event that the rat fell from the beam during
testing. The padding consisted of IACUC- and veterinarian-approved
disposable padded material that can be sanitized and covered by an ab-
sorbent pad. Rats received 1 training day, prior to their ﬁrst Tapered
Beam Test. The training day consisted of 4 training runs in the morning
(AM) and 2 additional training runs in the afternoon (PM). On theday of
testing, rats were allowed to acclimate to the experimental room for at
least 1 hour. The TBB Test consisted of 3 consecutive runs. Rats were
placed in the goal box for 5 min. The rat was then placed at the bottom
of the beam and allowed to migrate to the goal box. A 30 second rest
period in the goal box was provided between runs. The time to traverse
the beam and the number of foot slips were recorded.
Grip strength (GS). Rats, held by their tails, were gently pulled across
two push-pull gauges (San Diego Instruments, San Diego, CA) – one
for their forelimb and one for their hindlimb. The grip force for the
forelimbs and hindlimbs were recorded on their respective gauges.
Animals were tested in three consecutive grip strength trials, with
approximately 1 minute between each trial.
Open ﬁeld (OF). The automated open ﬁeld test was used to measure
the locomotor activity (distance traveled) and rearing frequency of
the rats. Animals were tested for 1 hour sessions. The open ﬁeld
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frames (9.5 × 18 inches) that were designed with a two dimensional
4 x 8 inch beam grid to monitor horizontal and vertical locomotor
activity. The activity was recorded by an automated system that
counts successive photobeam breaks. The rearing frequency and
distance traveled were recorded.
Accelerating Rotarod. Prior to study day 0, all rats were trained on a
Rotarod device (Omni-rotor treadmill, AccuScan Instruments, Inc.,
Columbus, OH) for 2 minutes to acclimate to the equipment. During
training, the rotation rate was set at 12 rpm. Each rat was placed on
the 7 cm diameter treadmill facing opposite the direction of the rota-
tion, and the time to theﬁrst fall and numbers of fallswere recorded. Ac-
celerating Rotarod performance was monitored once daily (1 trial/day)
for 5 consecutive days, beginning on the ﬁrst day of behavioral testing.
Testing was performed in a sound-attenuated room equipped with a
white-noise generation system set to 70 ± 10 db. For each daily trial,
the rat was ﬁrst placed on the treadmill as described above, and then
the Rotarod, set to increase at a constant acceleration rate from 0 to
40 rpm over a period of 60 seconds, was activated. When the animal
fell from the treadmill, the device was stopped, and the time on the
treadmill (latency to drop) was recorded.
Neurochemical characterization of Pink1, DJ-1 and Parkin KO rats
Striatum tissues were surgically removed from euthanized animals.
After weighing, tissue samples were immediately ﬂash frozen with
liquid nitrogen and stored frozen at approximately 70 °C until sample
processing. During analysis, tissue samples were homogenized on wet
ice with ice-cold 0.1% formic acid using a Kontes micro grinder at a
ratio of 1:9 [mg (weight): μL]. For the analysis of rat striatum samples,
aliquots of 50.0 μL of homogenates were added to a 96-well sample
plate (2-mL well size), followed by 50 μL of 0.1% formic acid solution
containing internal standards. The samples were further diluted with
350 μL of ice cold 0.1% formic acid (total 450 μL). Aliquots (200 μL)
of the diluted samples were transferred and ﬁltered through a
SupelcoHybridSPE® plate for the positive ion analysis (NE, DA, 5-HT,
and 5-HIAA). Second portions (200 μL) of the diluted samples were
ﬁltered through a Whatman ﬁlter plate for the negative ion analysis
(DOPAC and HVA). Because of limited sample size for mouse striatum
tissues (6–28 mg), Whatman ﬁlter plates were used to prepare the
diluted homogenates for both positive ion and negative ion modes of
analysis. Stock solutions of neurotransmitters were prepared in
ice-cold 0.1% formic acid at a concentration of 1.00 mg/mL, and
the stocks were sub-aliquoted into tubes (0.50 mL each) and stored
at −80 °C. Calibration standards were prepared from the stock
solutions with ice-cold 0.1% formic acid at various concentrations
on the day of the analysis. Quality control samples were prepared
in charcoal treated (2×) rat brain homogenates spiked with neu-
rotransmitters at four concentration levels (LLQC, LQC, MQC,
HQC). Quality control samples were sub-aliquoted into tubes
and stored at −70 °C. Triple-stage Quadrupole mass spectrometer
(API-4000) coupled with Waters Acquity UPLC® systems were used
for UPLC-MS/MS analysis.
Pathological characterization of Pink1, DJ-1 and Parkin KO rats
Perfusion
Animals were deeply anesthetized by an intraperitoneal injection of
sodium pentobarbital (75 mg/kg) and perfused in situ. The rats were
ﬂushed with approximately 75 mL of sodium cacodylate wash solution
then perfused with approximately 225 mL of sodium cacodylate-based
4% paraformaldehyde. The brains remained in the skull for approxi-
mately 24 hours at approximately 4 °C in sodium cacodylate-based
4% paraformaldehyde. Approximately 24 hours after perfusion, the
brains (including olfactory bulbs) were removed, weighed, and the
size were recorded. The intact brains were placed into sodiumcacodylate-based 4% paraformaldehyde for approximately 24 hours
at approximately 4 °C, and then placed into phosphate-buffered sa-
line for a minimum of 24 hours and maintained at approximately
4 °C until transport. Brains were shipped under ambient conditions
to NeuroScience Associates.
Embedding and sectioning
Animal brains were received at NeuroScience Associates, treated
overnight with 20% glycerol and 2% dimethylsulfoxide to prevent
freeze-artifacts, and multiply embedded in a gelatin matrices using
MultiBrain® Technology. After curing, the blocks were rapidly frozen
by immersion in isopentane chilled to −70 °C with crushed dry ice,
and mounted on the freezing stage of an AO 860 sliding microtome.
The MultiBrain® blocks were sectioned in the coronal plane at 40 μ.
All sections were collected sequentially into 24 containers per block
that were ﬁlled with Antigen Preserve solution (49% PBS pH 7.0,
50% Ethylene glycol, 1% Polyvinyl Pyrrolidone). Sections not stained
immediately were stored at−20 °C.
Immunohistochemistry
For immunochemistry, the sections were stained free-ﬂoating.
For tyrosine hydroxylase staining, rabbit Anti-TH primary antibody
(Pelfreeze, Cat #P40101-0))was used at 1:6000 dilution, and secondary
antibody was the goat anti-rabbit IgG-biotin at 1:238 dilution (Vector
Laboratories, Catalog # BA-1000). For alpha-synuclein staining, mouse
anti-aSyn primary antibody (BD Pharmingen, Catalog # 610786) was
used at 1:5000 dilution, and secondary antibody was the horse
anti-mouse IgG-biotin at 1:238 dilution (Vector Laboratories, Cat#
BA-2001). All incubation solutions from the blocking serum onward
used Tris buffered saline (TBS) with Triton X-100 (TX) as the vehicle;
all rinses were with TBS. Endogenous peroxidase activity was
blocked by 0.9% hydrogen peroxide treatment and non-speciﬁc binding
was blocked with 1.26% whole normal serum. Following rinses, the
sections were immunostained with a primary antibody overnight at
room temperature. Vehicle solution contained 0.3% Triton X-100
for permeabilization. Following rinses, sections were incubated in a
biotinylated secondary antibody for two hours at room temperature.
Sections were incubatedwith an avidin-biotin-HRP complex (Vectastain
Elite ABC kit, Vector Laboratories, Burlingame, CA) for one hour at
room temperature. Following rinses, the sections were treated with
diaminobenzidine tetrahydrochloride (DAB) and 0.0015% hydrogen
peroxide to create a visible reaction product, mounted on gelatinized
(subbed) glass slides, air-dried, dehydrated in alcohols, cleared in
xylene, and coverslipped with Permount.
Stereology
Stereology method and validation have been recently described
in detail (Healy-Stoffel et al., 2013). The Stereologer software package
(Stereology Resource Center, Baltimore INC, Baltimore, MD) was used
to estimate neuronal number with a Nikon Eclipse 80i microscope,
connected with a Sony 3CCD Color Digital Video Camera, which
operated an Advanced Scientiﬁc Instrumentation MS-2000 motorized
Stage input into a Dell Precision 650 Server and a high resolution
plasma monitor. Using design-based stereology, the number of
TH-positive neurons was quantiﬁed in the SNpc of the rats. For the
estimation of neuronal number, every 8thsection containing the SNpc
(Bregma −2.54 to −3.88 mm) was selected from a random initial
sort, described as systemic-random sampling. The section sampling
fraction (ssf) was 1/8 (West et al., 1991).In design-based stereology,
the optical disector method provides an equal probability for each
neuron to be counted in the estimation of the total number of neurons.
The counting process was as follows: First, each section was checked at
low magniﬁcation (4×) and the area of interest was precisely outlined
using a stereotaxic atlas of the rat brain. After outlining, the software
applied systematic random grids to select counting frames on the area
of interest. In each counting frame, TH-positive neurons were counted
Fig. 1. Targeting in exon 4 of the Pink1 gene. A. ZFN recognition site sequence. The two
ZFN binding sites are in bold uppercase. Cleavage site is in lower case. B. Schematic of
the gene structure of the ﬁrst 5 exons of the Pink1 gene. Exons are shown in ﬁlled
rectangles with exon number above. ATG, position of the translational start codon;
Δ26 bp marks the position of the 26 bp deletion in the colony, with nucleotide
sequence below. * indicates premature stop codons introduced by the 26 bp deletion
in exon 5. C. qRT-PCR analysis showing relative expression levels in wild type (WT) and
Pink knockout (Pink1−/−) rats.
Fig. 3. Targeting in exon 4 of the Parkin gene. A. ZFN recognition site sequence. The two
ZFN binding sites are in bold uppercase. Cleavage site is in lower case. B. Schematic of
the gene structure of the Parkin gene. Exons are shown in ﬁlled rectangles with exon
number above. ATG, position of the translational start codon; Δ5 bp marks the position
of the 5 bp deletion in the colony, with nucleotide sequence below. C. qRT-PCR analysis
showing relative expression levels in wild type (WT) and Parkin knockout (Parkin−/−)
rats. D. Western blots on PARKIN protein levels in wild type (+/+) and Parkin knockout
(−/−) rats,withGAPDH as loading control. Lanes 1 and 2 are rat brain cortexhomogenate
blotted using anti-PARKIN antibody #2132, and lanes 3 and 4, with anti-PARKIN
antibody #MAB5512.
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(yielding 3600×) by the optical disector principle, which utilizes the
disector probe (Sterio, 1984) in combination with optical sectioning
of the z-axis (or optical fractionator method) (West et al., 1991).
In the counting rule of the optical dissector, a neuron was counted
only if nucleoli came into focus within the counting frame without
touching the exclusion lines. The top and bottom of the sample
tissue were covered with a guard volume, which avoids an artiﬁcial
effect created from cutting the section with blade. This is called
“capping” or cutting the neurons in half. The guard height of the
present study was at least 3 μm in top and bottom (however,
it could be as high as 4 μm depending on the tissue thickness), asFig. 2. Targeting in exon 5 of the DJ-1 gene. A. ZFN recognition site sequence. The two ZFN
binding sites are in bold uppercase. Cleavage site is in lower case. B. Schematic of the gene
structure of the DJ-1 gene. Exons are shown in ﬁlled rectangles with exon number above.
ATG, position of the translational start codon;Δ9 bp± 1 bpmarks the position of the 9 bp
deletion with 1 bp insertion in the colony, with nucleotide sequence below. * indicates
premature stop codons introduced by the in/del in exon 6. C. qRT-PCR analysis showing
relative expression levels in wild type (WT) and DJ-1 knockout (DJ-1−/−) rats. D.Western
blots on DJ-1 protein levels in wild type (±/±) and DJ-1 knockout (−/−) rats, with actin
as loading control. Lanes 1, 3 and 5 are striatum lysis from three individual knockout rats,
and lanes 2, 4 and 6 are striatum lysis from three individual wild type rats. Molecular
weight standard is shown on the left and protein identity, on the right.measured by linear encoder. The 10–12 μm middle of 18–21 μm
thick sample was analyzed. The thickness of each section was
determined by the mean thickness of count frames measured by a
100×/1.4 aperture oil immersion lens and a linear encoder. After
every sample section was analyzed, the total number of TH-
positive neurons in the interest area (N) was estimated by multi-
plying the number of counted neurons (ΣQ) by the reciprocals of
three sample fraction such as the section sampling fraction (ssf),
the area sampling fraction (asf), and the section thickness sam-
pling fraction (stsf). The Stereologer software package (Stereology
Resource Center, Baltimore INC, Baltimore, MD) calculated the
total neuronal number.
N ¼
X
Q  1
ssf
 
 1
asf
 
 1
stsf
 
The average number of slides varied from 5–7 per animal and the
Coefﬁcient of Error (CE) was capped at .15 with the actual mean value
of 0.07.
Statistical analyses. Data throughout the paper are expressed as
mean average ± SEM for a given sample size. Statistical analysis
was performed by means of, when appropriate, either a one-way
analysis of variance (ANOVA) or a two-way analysis of variance
with age and genotype as the two variables. Post-hoc tests
(Dunnett's test for one-way ANOVA and Bonferroni multiple com-
parisons test for two-way ANOVA)were used with signiﬁcance set
at p b 0.05.
Results
Generation of KO rats
MJFF partneredwith SAGE Labs (St. Louis, MO) to generate novel rat
modelswith ZFN-mediated targeted disruption of geneswithmutations
causally linked to PD through human genetic studies. ZFNs are fusion
proteins of a zinc ﬁnger protein and DNA endonuclease domain of
a type II restriction enzyme, FokI (Geurts et al., 2009). ZFNs are
engineered to speciﬁcally bind and cleave at speciﬁc chromosomal
loci to generate double strand breaks, repair of which by the non-
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Fig. 4. Pink1 and DJ-1 KO rats display behavioral abnormalities. Homozygous Pink1 KO (n = 7), homozygous DJ-1 KO (n = 7) and Long Evans wild type rats (n = 7) were
tested at 4, 6 and 8 months of age. (A) Motor Movements: Automated open ﬁeld apparatus consisting of photobeam breaks to monitor horizontal and vertical locomotor
activity was used to measure rearing frequency (Left) and total distance travelled (Right). (B) Motor Strength: Grip Strength was measured by obtaining grip force on
push-pull gauges for both the forelimb (Left) and hindlimb (Right). An average was taken for three consecutive grip strength trials, with 1 minute between each trial.
(C) Motor Coordination: Numbers of foot slips were measured in a tapered balance beam apparatus. Rats were placed at the bottom of the beam and allowed to migrate
up to the goal box which was 58 cm from the ﬂoor. The numbers of forelimb (Left) and hindlimb (Right) foot slips were recorded. An average was taken for three
consecutive runs, with 30 seconds between each trial. *P b 0.01, signiﬁcantly different from wild type, 2-way Repeated Measures ANOVA, followed by Bonferroni multiple
comparisons. Data are represented as means ± SEM.
195K.D. Dave et al. / Neurobiology of Disease 70 (2014) 190–203homologous end joining pathway results in insertions/deletions that
potentially disrupt the gene function (Gaj et al., 2012). A pair of ZFNs
were each designed and conﬁrmed to cleave within exon 4 of the
Pink1 gene, exon 5 of the DJ-1 gene and exon 4 of the Parkin gene
(Figs. 1A, 2A and 3A). A founder with a 26-bp deletion in the Pink1
exon 4, a founder carrying a 9-bp deletion along with a 1-bp insertion
in the DJ-1 gene, and a founder containing a 5-bp deletion in the Parkingene were bred to establish a colony for each of the knockout models.
All three mutations led to a frame-shift that resulted in a premature
stop codon in the exon immediately following (Figs. 1B & 2B). Quantita-
tive RT-PCR detected very little mRNA in homozygous animals of either
Pink1 or DJ-1rats (Figs. 1C & 2C) indicating that the deletion mutations
also destabilized the mRNA. Parkin mRNA levels were decreased ap-
proximately 50% in ParkinKOrats (Fig. 3C) indicating that this transcript
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197K.D. Dave et al. / Neurobiology of Disease 70 (2014) 190–203was also destabilized, but not completely, consistent with Parkin
KO mice (Goldberg et al., 2003). Western blots conﬁrmed that DJ-1
knockout rats in fact lack DJ-1 protein (Fig. 2D). Western blots with
two different epitope-mapping antibodies showed that Parkin KO rats
did not contain any detectable Parkin protein (Fig. 3D).Wewere unable
to conﬁrm lack of Pink1 protein due to lack of speciﬁc antibodies against
Pink1 protein. These homozygous gene knockouts were not embryoni-
cally lethal, and appeared to be normal at birth. In agreement with the
qRT-PCR data, PCR array analysis on the expression levels of genes
involved in PD pathways in all three knockout rat models conﬁrmed
speciﬁc and signiﬁcant reduction of the target mRNA in DJ-1 and Pink1
knockout rats, whereas Parkin mRNA was only halved (Sun et al., 2013).
No other genes were substantially altered at the mRNA level.
Behavioral phenotyping of KO rats
To investigate if loss of Pink1, DJ-1 or Parkin in the rats results
in behavioral alterations, we performed systematic and detailed
characterization at 4, 6 and 8 months of age. Separate groups of
rats (n = 15/age/genotype) were tested in the functional observa-
tional battery (FOB) assay, accelerating rotarod and gait measures
at Wil Research. There were no signiﬁcant differences observed in
the following outcome measures for any of the genotypes at any
of the three ages (data not shown): convulsions/tremors, feces consis-
tency, biting, palpebral (eyelid) closure, ease of removal from cage,
lacrimation/chromodacryorrhea, piloerection, eye prominence,
red/crusty deposits, ease of handling animal in hand, salivation,
fur appearance, respiratory rate/character, mucous membranes/
eyes/skin color, grooming, bizarre/stereotypic behavior, time to
ﬁrst step, urination/defecation, backing, approach response, startle
response, pupil response, touch response, tail pinch response, eyeblink
response, body temperature or catalepsy. Additionally, there were no
signiﬁcant differences observed in latency to drop in the accelerating
rotarod paradigm at any of the ages tested (data not shown).
Both Pink1 and DJ-1 KO rats, but not Parkin KO rats, showed
impaired gait and motor features in subjective outcome measures. Six
out of ﬁfteen Pink1 KO rats exhibited impaired gait movement, and
air-righting reﬂex at 8 months of age(data not shown). Similarly, ﬁve
out of ﬁfteenDJ-1 KO rats showed impairment in gait and air-righting
reﬂex at 8 months of age. Pink1 and DJ-1 KO rats exhibited normal
gait and air-righting reﬂex at 4 and 6 months of age. Additionally,
at 8 months of age, 13 out of 15 Pink1 KO rats and 9 out of 15 DJ-1 KO
rats showed lack of hind-limb extensor strength and lack of overall
muscle tone (data not shown). The affected rats appeared to drag
hindlimbs while ambulating which could be observed in both the
open-ﬁeld and in the home-cage environment. Parkin KO rats were
not impaired in any of the outcome measures tested. There was no
increase in mortality rate despite the gait and motoric deﬁcits observed
in Pink1 and DJ-1 KO rats up to 8 months of age.
To follow up on the dysfunction in the behavioral measures
observed in Pink1 and DJ-1 KO rats in WIL Research studies, a different
group of homozygous Pink1 and DJ-1 KO rats (n = 7/genotype) were
further tested at Psychogenics Inc. in more extensive behavioral assaysFig. 5. Pink1 and DJ-1 KO rats display dysfunction in paw positioning and gait- Fig. 5A explains
animal of each genotype at each age time point which are compiled and graphed as a bar graph
modiﬁed animal (here Pink1KO at 4 month of age) fromWTcontrol agematched animals. Featu
proprietary algorithm and feature value differences on the bar graph are shown in their ranke
original features were formed and the scatter plots of animals from each group in the axes of t
the Gaussians approximating each group in this new feature space served as a measure of si
calculation was weighted by the corresponding weight of that feature and the statistical signiﬁ
pane) as described in Appendix A. Each quantitative assessment (bar graph) from the group
(heat map) allowing for easier visual assessment of paw positioning distortion. Color scheme
following scale from red corresponding to the highest and blue to zero count. Fig. 5B is the gra
in movement (heat map) for each genotype (WT, Pink1 KO and DJ-1 KO) at two different ages
normal oblong shapes for the hindlimbs and two smaller ones which even fused for the forelim
hindlimb positioning surfaces have more the shapes of square and the zones between left an
forelimbs. This indicates less accuracy in limb positioning in space and a lack of coordination of t
using pattern recognition approach were also obtained as described in Appendix A.including mobility in the open-ﬁeld, rearing frequency, grip strength,
tapered balance beam performance, and NC gait apparatus. In this
study, the same Pink1 and DJ-1 KO rats were re-tested at 4, 6 and
8 months of age. Parkin KO rats were not tested in these additional
behavioral studies due to the lack of any gait/motor phenotype in the
preliminary studies at WIL Research. There was a robust reduction in
the rearing frequency in both Pink1 KO and DJ-1 KO rats compared
to WT rats with signiﬁcant main effect for genotype, F(2, 18) = 27.59,
p b0.0001, but not with age F(2, 36) = 2.72, p = 0.07 (Fig. 4A). There
was signiﬁcant interaction between age and genotype for rearing
frequency F(4, 36) = 5.76, p = 0.0011 with more than 50% reduction
observed at 8 months of age in both genotypes. There was also a signif-
icant reduction in total distance travelled in the Pink1 KO rats at all ages
with 70% decrease in mobility observed at 8 months of age, but not
in the DJ-1 KO rats (Fig. 4A). There was a signiﬁcant main effect for
both age F(2, 36) = 23.68, p b 0.0001, and genotype F(2, 18) = 25.53,
p b 0.0001, and signiﬁcant interaction F(4, 36) = 3.90, p = 0.0099.
Motor strength in KO vs. WT rats, as measured by limb grip strength
showed no signiﬁcant main effects in age, genotype or interaction in
forelimb grip strength (Fig. 4A). However, hindlimb grip strength was
greatly impaired with signiﬁcant main effect for age F(2, 36) = 17.10,
p b 0.0001, for genotype F(2, 18) = 19.91, p b0.0001 and signiﬁcant
interaction F(4, 36) = 3.24, p = 0.0226 (Fig. 4B). Interestingly, deﬁcit
in hindlimb grip strength was present as early as 4 months of age and
persisted through 8 months of age. Motor coordination was measured
by counting the number of forelimb and hindlimb foot slips in the
tapered balance beam paradigm. There was signiﬁcant dysfunction
of motor coordination in Pink1 KO rats, but not the DJ-1 KO rats,
as compared to WT (Fig. 4C). The number of forelimb foot slips
increased ﬁve-fold in both 6 and 8 month old Pink1 KO rats with sig-
niﬁcant main effects for age F(2, 36)= 9.03, p b 0.0001, for genotype
F(2, 18) = 35.79, p b 0.0001, and signiﬁcant interaction F(4, 36) =
3.09, p = 0.0278. The 4 month old Pink1 KO rats were not signiﬁ-
cantly different from WT. In contrast, the number of hindlimb foot
slips in the balanced beam increased 3–5 fold at all three ages
in Pink1 KO rats (Fig. 4C). There was a signiﬁcant main effect for
age F(2, 36) = 5.19, p = 0.0105, for genotype F(2, 18) = 39.41,
p b 0.0001, but no signiﬁcant interaction of age and genotype
F(4, 36) = 1.26, p = 0.3020. Similar to forelimb foot slips, there
were no signiﬁcant differences in the DJ-1 KO rats compared to
WT in the hindlimb foot slips.
Wild type rats weighed 469 g± 11.9, 548 g± 14.5, and 587 g± 18.4
for 4, 6, and 8 months respectively. DJ-1 KO rats weighed 471 g ± 14.8,
532 g ± 18.0, and 556 g ± 23.7 for 4, 6, and 8 months respectively.
Pink1 KO rats were heavier than WT counterparts with 551 g ± 15.0,
653 g ± 20.5, and 651 g ± 27.8 for 4, 6, and 8 months respectively.
There were signiﬁcant main effect for age F(2, 36) = 121.03,p b 0.0001,
and for genotype F(2, 18) = 9.12, p= 0.0018, but no signiﬁcant interac-
tion F (4, 36)= 2.56, p= 0.0547. Gait wasmeasured using NC apparatus
looking at geometry and dynamic features. Both DJ-1 KO rats and Pink1
KO rats even at 4 months of age show substantial gait dysfunction com-
pared toWT (Fig. 5). By looking at pawplacement (part of gait geometry),the paw positioning heat map generation: Gait geometry features are captured from each
representing phenotype difference for each of the feature values represented of genetically
res are ranked in their ability to discriminate Pink1 KO andWT groups using PsychoGenics
d order from top to bottom (left pane). De-correlated statistically combinations of these
he two most discriminative (new) combined features (right upper plane). The overlap of
milarity as described in Appendix A. Contribution from each new feature to the overlap
cance of the overlap (due to the intra-group variability) was also estimated (right bottom
of paw positioning features has been also transposed into a more visual representation
(blue to red) represents number of paw prints placed in the respective surface using the
phical representation of paw prints distribution with respect to the body center of animal
(4 and 8 months). On the two top panels, the four limbs have been represented with two
bs at older age inWT animals. For Pink1 (middle panels) and DJ-1 KO (bottom panels), the
d right are less deﬁned as surfaces are merging. Same observation can be made for the
he four limbswhile animal is inmovement. Quantitativemeasure of phenotype differences
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Fig. 6. Pink1 and DJ-1 KO rats have increased DA and 5-HT striatal content – left and right striata from homozygous Pink1 KO rats, homozygous DJ-1 KO rats, andWT rats (n = 6/group/age)
were analyzed via ultra-high performance liquid chromatography-MS/MS for neurotransmitter content of dopamine, serotonin and their metabolites. Results showed a signiﬁcant two- to
three-fold increase in DA (6A) and 5-HT (6B) at 8 months of age in both Pink1 and DJ-1 KO rats. Parkin KO rats were not signiﬁcantly different compared to WT. Data are represented as
means ± SEM.*P b 0.01, signiﬁcantly different from wild type, 2-way ANOVA, followed by Bonferroni multiple comparisons.
198 K.D. Dave et al. / Neurobiology of Disease 70 (2014) 190–203Pink1 and DJ-1 KO rats showed an abnormal paw positioning from the
centre of the animals' bodywhile inmotion compared toWTrats translat-
ing by a lack of accuracy in positioning their limbs relative to the body's
centre. Regarding gait dynamics, both lines at 4 and 8 month of age
showed shorter duration in stride, swing and stance when compared to
the age matched WT controlled animals (Discrimination and p values
for Pink1 and DJ-1 respectively at 4 months: 83% (p = 0.013) and 84%
(p = 0.026) and at 8 month: 89% (p = 0.017) and 90% (p = 0.014))
(Fig. 9) (see analysis for signiﬁcant differences in Appendix A).
Neurochemical phenotyping of KO rats
At the end of the behavioral testing in theWIL Research study, left
and right striata (n = 6/group/age) were collected, and ultra-high
performance spectroscopy (UPLC)-MS/MS was used to measure con-
centrations of dopamine, serotonin, 3,4-dihydroxyphenylacetic
acid (DOPAC), Homovanillic acid (HVA), and 5-Hydroxyindoleacetic
acid (5-HIAA). Concentrations from left and right striata were averaged
for each animal. There was a signiﬁcant 2–3 fold increase in striatal
dopamine in both KO rats at 8 months of age with signiﬁcant effect of age
F(2, 45) = 35.28, p b 0.0001, signiﬁcant effect of genotype F(2, 45) =
5.23, p = 0.0091, and a signiﬁcant interaction F(4, 45) = 10.70,
p b 0.0001 (Fig. 6A).Similar to DA levels, striatal 5-HT levels also
increased 2–3 fold at 8 months of age with signiﬁcant effect of age
F(2, 45) = 18.39, p b 0.0001, genotype F(2, 45) = 5.90, p = 0.0053,
and a signiﬁcant interaction between age and genotype F(4, 45) =
4.29, p = 0.0051 (Fig. 6B). Dopamine turnover was calculated by
using the equation (DOPAC ± HVA/DA)*100. Serotonin turnover was
calculated by using the equation (5-HIAA/5-HT)*100. There were no
signiﬁcant differences in the overall rate of DA or 5-HT turnover for
either Pink1 or DJ-1 KO rats (data not shown). Parkin KO Rats were
not signiﬁcantly different fromWT rats at any of the ages tested.
Pathological phenotyping of KO rats
At the end of the behavioral testing in theWil Research study, brains
were collected (n = 9/group/age), and immunohistochemistry was
performed to examine tyrosine hydroxylase (TH) and alpha-synuclein
(aSyn) staining. Nigral TH-immunoreactivity was substantially reduced
in both Pink1 and DJ-1 KO rats at 6 months and 8 months of age
compared to the WT rats (Fig. 7A). The ventral tegmental area (VTA)
TH immunoreactivity remained unchanged at all ages. Unbiased
stereology was performed to count the number of TH-positive neurons
using Nissl as a counterstain for cell bodies. There were signiﬁcant
age-related decreases in numbers of TH positive neurons in SN of both
Pink1 and DJ-1 KO rats (Fig. 7B). There was an average of 25% reduction
at 6 months and over 50% reduction at 8 months of age in both geno-
types with signiﬁcant main effect for age F(2, 72) = 14.31, p b 0.001,
and for genotype F(2, 72) = 6.81, p = 0.0020, and signiﬁcant interac-
tion of age and genotype F(4, 72) = 3.37, p = 0.0139. Parkin KO rats
were not signiﬁcantly different fromWT rats even though there was asmall 20% reduction observed at 8 months of age. To verify that this
substantial loss of SNpc neurons represents neuronal loss rather than
a loss of dopaminergic phenotype or simply a loss of TH expression,
parallel Nissl counts were performed in the same sections to obtain
total number of neurons in the 8-month old rats. The average total num-
ber of neurons in Long Evans WT rats was 54544 ± 3660. One-way
ANOVA showed that there was a signiﬁcant reduction (approximately
40%) in the total number of neurons in DJ-1 KO and Pink1 KO, but not
Parkin KO rats F(3, 32) = 16, p b 0.001. The average for the total num-
ber of neurons for DJ-1, Pink1 and Parkin KO rats were 32240 ± 2553,
33348 ± 2701, and 51148 ± 2655, respectively. There are several
factors as to the high counts of nigral cells reported in this
study which complicate the comparison versus other publications.
Methodological differences in delineation of SNpc boundaries, data
collection (2d versus 3d), magniﬁcation (100× versus 3600×) or type
of stereology (method-based versus design-based) can lead to differ-
ences in numbers of cell counted, even within the same tissue. The cur-
rent study used design-based 3d stereology with high magniﬁcation
(3600×),whichmay have resulted in higher neuronal counts compared
to more recent publications (Cannon et al., 2013; Healy-Stoffel et al.,
2012; Healy-Stoffel et al., 2013; Tapias et al., 2013)
Despite the robust and progressive loss of DA neurons in the SN pars
compacta in both genotypes, there were no changes in TH-immuno
reactivity in striatum at any of the three ages as quantiﬁed by optical
densitometry (representative 8 month picture shown in Fig. 8).
Staining for αSyn using antibody against total αSyn revealed no
increase in the striatum or any other brain region in Pink1, DJ-1 or
Parkin KO rats compared to WT (representative 8 month striatal
staining shown in Fig. 8).
Discussion
The results of these studies demonstrate that loss of either Pink1
gene or DJ-1 gene produces a robust behavioral dysfunction and a
signiﬁcant loss of SN DA neurons in rats. Motor impairments in
movement, strength and coordination precede nigral neuronal loss.
The neurodegeneration is rapid between 4 and 8 months of age
with about 50% decrease seen at 8 months of age. In both models,
the nigral neurodegeneration does not correlate with changes in
striatal TH or alpha-synuclein immunoreactivity; however, there is
a 2-3 fold increase in both DA and 5-HT striatal content at 8 months
of age in both rats models. Parkin KO rats were not different from WT
rats in any of the behavioral, neurochemical and pathological outcome
measures.
Mutations in Pink1, DJ-1 and Parkin genes, although rare, have been
causally linked to early-onset PD presumably due to a loss of function of
these genes (Bonifati et al., 2003; Kitada et al., 1998; Valente et al.,
2004). The protein encoded by the Pink1 gene is a serine-threonine
kinase,which has been suggested to provide protection against oxidative
Fig 8. Pink1 and DJ-1 KO rats have no changes in TH or alpha-synuclein pathology
in the striatum – homozygous pink1 KO rats, homozygous DJ-1 KO rats, and WT
rats (n = 9/group/age) were perfused with paraformaldehyde. Fixed brains were
sectioned and stained with antibodies against tyrosine hydroxylase or total alpha-
synuclein. There were no changes observed in TH or alpha-synuclein immunoreactivity
at any of the three ages. Representative pictures of rats from each of the three groups at
8 months of age are shown. Scale bar = 2 mm. There was no reduction in TH staining
in the striatum despite robust loss of nigral neurons. There were no changes in alpha-
synuclein immunoreactivity in the striatum.
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Fig. 7. Pink1 and DJ-1 KO rats exhibit a progressive loss of dopaminergic neurons in the
Substantia nigra – homozygous pink1 KO rats, homozygous DJ-1 KO rats, and WT rats
(n = 9/group/age) were perfused with paraformaldehyde. Fixed brains were sectioned
and stained with tyrosine hydroxylase antibody and counterstained with Nissl stain to
reveal cell bodies. Fig. 7A is representative staining from one rat from each of the
three groups at each age. Immunohistological pictures show a progressive decrease in
TH-immunoreactivity in the substantia nigra in both KO rats. Scale bar = 1 mm. Design-
based unbiased stereology was used to identify and estimate neuronal number in the
Substantia nigra pars compacta region using TH and Nissl staining. Fig. 7B shows that
there was a signiﬁcant and robust (greater than 50%) loss of nigral dopaminergic neurons
between 4 and 8 months of age in both Pink1 and DJ-1 KO rats. Parkin KO rats were
not signiﬁcantly different from WT. Data are represented as means ± SEM.*P b 0.01,
signiﬁcantly different from wild type, 2-way ANOVA, followed by Bonferroni
multiple comparisons.
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degradation/mitophagy and maintaining mitochondrial homeostasis
(Springer and Kahle, 2011). Pink1 deﬁciency in mammalian neurons
alters mitochondrial buffering capacity, increased reactive oxygen
species and impaired respiration (Gandhi et al., 2009), suggesting a
mechanism by which Pink1dysfunction would confer vulnerability to
cell death. While the exact function(s) of DJ-1 protein have not been
fully elucidated, it is thought to serve as a sensor of oxidative stress
switching its isoelectric point to a more acidic form following oxidative
stress (Mitsumoto andNakagawa, 2001). Indeed, DJ-1 deﬁciency in var-
ious cell types including cultured mouse neurons, cell lines and DJ-1
patient derived lymphocytes led to mitochondrial dysfunction and
increased sensitivity to oxidative stress (Irrcher et al., 2010). Parkin is
an E3 ubiquitin ligase which has been shown to ubiquitinate substrates
and to trigger proteasome-dependent degradation (Zhang et al., 2000),
thus playing an important role in neuronal homeostatic processes.
Accumulation of data over the years have suggested that these three
protein enzymes serve to regulate mitochondrial function especially
in response to oxidative stressors and that dysregulation of this function
may confer vulnerability to nigral cell death (Cookson, 2010; Trempe
and Fon, 2013). Due to the apparent loss of function mutations in
these genes that may cause PD, genetic models based on gene knockout
approaches may provide good construct validity.Mouse knockout models of either Pink1 or DJ-1 gene have been
shown to exhibit behavioral and neurochemical deﬁcits, without a
signiﬁcant loss in nigral neurons and without any increase in total or
aggregated alpha-synuclein. For example, mice lacking Pink1exhibited
no change in dopaminergic neuron numbers, had normal dopamine
concentration in the striatum and no changes in DA receptor density,
however, evoked DA release from catecholamine terminals was greatly
impaired (Kitada et al., 2007). DJ-1KO mice were reported to have be-
havioral dysfunction in motor activity, grip strength and progressive
gait abnormalities despite lack of any pathological changes (Chandran
et al., 2008). Parkin deﬁcient mice displayed abnormal behavior in
beam walk and adhesive removal tests, and a decrease in synaptic
excitability in the striatum despite showing normal numbers of nigral
dopaminergic neurons (Goldberg et al., 2003). Even mice lacking all
three recessive genes of Pink1, DJ-1 and Parkin genes exhibited normal
morphology and numbers of dopaminergic neurons up to 24 months
of age (Kitada et al., 2009), suggesting that these three genes are not
critical for survival of nigral neurons in the mouse.
In the current study, we observed normal numbers of dopamine
neurons in the SN of both Pink1 and DJ-1 rats at 4 months of age as
compared to Long Evanswild type, suggesting that the deﬁcits observed
at later ages were not developmental in origin. By 6 months of age,
both Pink1 and DJ-1 KO rats started to show signiﬁcant impairments
in motor behaviors and these deﬁcits persisted to 8 months of age. At
the same time (6 months), nigral neuronal counts were only reduced
by 25 percent indicating that behavioral deﬁcits precede dopaminergic
cell loss and that the behavior deﬁcits may reﬂect neuronal dysfunction
that likely occurs prior to loss of cell bodies in the SN. One possible
explanation for such species differences could be the distribution
and expression of these proteins in the rodent brain. However,
neuroanatomical distribution of these proteins is similarly widespread
and heterogeneous in both species (Bandopadhyay et al., 2005; Stichel
et al., 2000; Taymans et al., 2006). It is also possible that the deﬁciency
of one of these proteins leading to disruption of mitochondrial
homeostasis confers higher vulnerability to aging-related oxidative
Fig. 9.Gait dynamic features analysis of Pink1 KO andDJ-1 KO at 4 and 8 months of age: The two top panels represent gait features difference of Pink1 KO compared toWT agematched control
animals at 4 and8 monthof age. The twogroups represented as ablue cloud (Pink1KO) anda red cloud (WT) arewell separatedwith adiscrimination (andp) value of 83% (p= 0.013) and89%
(p= 0.017) at 4 and 8 months respectively. The two bottom panels represent gait features difference of DJ-1 KO compared toWT agematched control animals at 4 and 8 month
of age. The twogroups represented as a blue cloud (DJ-1 KO) and a red cloud (WT) arewell separatedwith a discrimination (andp) value of 84% (p= 0.026) and 90% (p= 0.014) at 4 and
8 months respectively. Both lines show a faster gait dynamic (decrease in durations of stance, stride and swing) compared to WT control animals at 4 and 8 month of age.
200 K.D. Dave et al. / Neurobiology of Disease 70 (2014) 190–203stress in rats compared to mice. Few studies have explored such
species differences in mitochondrial function (Lash et al., 2001;
Panov et al., 2007); however, further systematic studies would
need to explore differences due to species or strain as a function of
gene deﬁciency in rats versus mice. Such studies could also shed
light on the lack of any phenotype observed in Parkin KO rat despite
robust phenotypic differences seen in Pink1 and DJ-1 KO rats
compared to WT. It is possible given the trend in a small, albeit not
signiﬁcant, reduction in dopamine neurons, in 8 month old ParkinKO rats that a potential PD-like phenotype is delayed warranting
further characterization in older aged rats.
Pink1 and DJ-1 KO rats do not display other features of clinical PD
phenotype. In the current study, an increase in striatal dopamine was
observed at the same time as gross behavioral dysfunction and ﬁfty
percent loss of nigral cells. Striatal dopamine levels have not always
correlated with behavioral function in genetic models of PD. DJ-1
knockout mice that were reported to develop progressive behavioral
abnormalities in gait, muscle strength and motor activity had normal
Fig. A1. Difference in feature values and feature ranks (red curve with green squares).
Relative difference (%) between feature values in two different sets is calculated and
plotted in the order corresponding to feature ranks together with their ranks varying
from 0 to 100%.
201K.D. Dave et al. / Neurobiology of Disease 70 (2014) 190–203striatal dopamine function (Chandran et al., 2008), while others,
in agreementwith the current ﬁndings, have reported increased striatal
dopamine content accompanying behavioral deﬁcits (Chen et al., 2005;
Manning-Bog et al., 2007). Increased dopamine function at the level of
the striatum has been proposed as functional presynaptic compensa-
tion resulting from nigrostriatal damage (Eberling et al., 1997;
Hornykiewicz, 2001). Indeed, many parameters of striatal dopamine
function such as total content, release, turnover, and uptake have
been shown to be signiﬁcantly increased after nigral cell loss (Snyder
et al., 1990; Zigmond et al., 1984). However, this compensation seems
to be linked to the degree and severity of the nigrostriatal damage,
with moderate lesions of the nigra producing an increase in dopamine,
and progressively severe lesions resulting in eventual reduction in
striatal dopamine, as seen with unilateral 6-OHDA lesion in the rat
(Bergstrom et al., 2001) and MPTP lesion in the squirrel monkey
(Perez et al., 2008). Based on theseﬁndings, it is possible that phenotyp-
ic characterization of Pink1 and DJ-1 KO rats at later ages may show
more severe neurodegeneration and lower striatal dopamine function.
The concurrent increase in striatal 5-HT content in the current study
may be part of compensatory changes proposed to happen in non-
basal ganglia related structures and non-catecholamine circuitries that
feed into and out of the nigrostriatal system (Bezard et al., 2001). In
support of this hypothesis, several studies of dopamine depletion have
reported an increase in 5-HTneuronal ﬁring (Wang et al., 2009), seroto-
nergic innervation (Guerra et al., 1997), and similar to the current
study, an increase in 5-HT concentrationwithout a change inmetabolite
5-HIAA levels (Hennis et al., 2014). Alternatively, Pink1 and DJ-1 genes
may affect 5-HT function independently of the nigrostriatal neurode-
generation, by directly inﬂuencing vescicular and presynaptic function
through mitochondria activity and energy maintenance (Morais et al.,
2009; Usami et al., 2011). Future studies determining evoked release,
synaptic connectivity, axonal swellings, or other measures of neuro-
transmitter system integrity(such as DAT, VMAT, NET, SERT binding)
may shed more light on whether early striatal dysfunction is correlated
with early behavioral deﬁcits observed in these models.
In the preliminary analyses performed for synuclein staining, there
was no change in alpha-synuclein immunoreactivity within the SN,
striatum or any other brain areas in Pink1, or DJ-1KO rats suggesting
that synuclein pathology may not be directly responsible for the neuro-
degeneration observed in these KO rats. Due to the lack of reports of
post-mortem examinations of patients with DJ-1 mutations (Cookson,
2010), we do not yet know the severity of neuronal loss or whether
they have Lewy bodies. Recent pathological studies have shown Lewy
bodies in Pink1-linked Parkinsonism and some cases of Parkin-linked
Parkisonism (Farrer et al., 2001; Miyakawa et al., 2013; Poulopoulos
et al., 2012; Pramstaller et al., 2005; Samaranch et al., 2010; Sasaki
et al., 2004). In the context of current ﬁndings, more stringent charac-
terization of protein levels (e.g. proteinase-K digestion) with antibodies
to different epitopes, antibodies against different species, and antibod-
ies against pathological phosphorylated species need to be performed
in future to conﬁrm absence of synuclein pathology.
The current behavioral, neurochemical and pathological characteri-
zation was intended as a basic collection of essential PD-relevant
phenotypic data. MJFF hopes that the availability of these animals will
better position the research community to conduct more specialized,
detailed and extensive characterization that caters to different research
interests. In summary, our ﬁndings from single KO rat studies demon-
strate that lack of either Pink1 or DJ-1 protein is sufﬁcient to cause
dopaminergic neurodegeneration in rats. These results support the
conclusion that these proteins are critical for survival of nigral neurons
in rats. Furthermore, absence of these proteins results in gross motor
impairments in several behavioral outcome measures in rats. The
results of this study support the use of the Pink1 andDJ-1 KO ratmodels
for elucidating biological and pathological changes that occur in
autosomal recessive, early onset PD and provide a critical research
tool to explore therapeutic approaches.Conﬂict of interest
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Appendix A. Quantitative assessment of disease phenotype using
De-correlated ranked feature analysis (DRFA)
The outcome from PsychoGenics' automated platforms (NeuroCube
as well as from other “Cubes”) is a large set of features (behavioral
parameters) that can be used for various analyses. Many of these
features are correlated. Therefore, we form statistically independent
combinations of the original features (further referred to as de-correlated
features). Each de-correlated feature extracts information from the
whole cluster of the original features, so the new feature space has
lower dimensionality.
Next, we apply a proprietary feature ranking algorithm to score each
feature discrimination power (ability to separate the two groups,
e.g. control and disease). Ranking is an important part of our analyses
because it weighs each feature change by its relevance for discrimina-
tion of these particular two groups: if there is a signiﬁcant change
in some irrelevant feature measured for a particular phenotype, the
Fig. A2. Visualization of binary discrimination in the ranked de-correlated feature space.
The two highest ranked de-correlated features are chosen to form the 2D coordinate
plane for visualization purposes. Each dot represents a mouse. Mice from the control
group are shown as blue dots and mice from the disease group are plotted in red. The
other convenient (from the scale perspective) but totally equivalent measure derived
from the cloud overlap is discrimination probability = 1 – overlap, which measures
how reliably a classiﬁer can be trained to discriminate between groups A and B above
the chance level, zero corresponding to 100% overlap and no ability to distinguish the
two groups above the chance level, whereas 100% meaning the error free discrimination.
202 K.D. Dave et al. / Neurobiology of Disease 70 (2014) 190–203low rank of this feature will automatically reduce the effect of such
change in our analyses, so we don't have to resort to the conventional
“feature selection” approach and discard information buried in the less
informative features.
Ranking algorithm can be applied to either original or the new
features to gain insight about the key control-disease differences
(see Fig. A1).
Feature analysis: quantitative assessment of disease phenotype
In the new feature space, the overlap between the “clouds” (Gaussian
distributions approximating the groups of mice in the ranked de-
correlated features space) serves as a quantitativemeasure of separability
(“distinguishability”) between the two groups (see Fig. A2). For visualiza-
tion purposes, we plot each cloud with its semi-axes equal to the one
standard deviation along the corresponding dimensions. Note, however,
that while the overlap between any two Gaussian distributions is always
non-zero, it may not necessarily be seen at the “1-sigma level”.Fig. A3. Calculation of discrStatistical signiﬁcance of the discrimination value can be estimated
in the following way. First, each labeled set of subjects is randomly
split with 1:3 ratio, where larger groups from each set are used to
calculate discrimination probability calculated with the procedure
described above. This procedure is repeated multiple times with
different random splitting for each iteration to build distribution of
“true” discrimination probability ptrue as shown in green color in
Fig. A3 (step 1). Next, all subjects from both groups are combined
together without individual class labels (step 2). Similarly to the
previous step, this set is split randomly multiple times. After many
iterations, distribution of “random” discrimination probability prandom
is built as shown in cyan color in Fig. A3 (step 2). Both distributions
are normalized and their mutual weighted overlap is calculated.
The resulting value is a generalized quantity of what is well known
as p-value of statistical signiﬁcance.References
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